EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Selected traditional Chinese medicine preparations for the prevention and treatment of sarcopenia: a critical narrative review

Bo Wu, Yuqi Jia, Mingzhang Zhou, Zhongren Hu, Yanchi Chen, Ying Wei, Yan Liu, Mingxing Hou

Frontiers in Pharmacology · 17.11.2026 · 17

DOI: 10.3389/fphar.2026.1975090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 17.11.2026. Verfasst von Bo Wu und 7 weiteren Autor:innen. Die Arbeit nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Inner Mongolia Autonomous Region.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the absence of approved pharmacotherapy for sarcopenia, selected traditional Chinese medicine (TCM) preparations—including multi-herb formulae, botanical extracts, and isolated bioactive metabolites—have attracted experimental interest, but the reliability and clinical relevance of the evidence remain uncertain. This critical narrative review synthesizes English- and Chinese-language preclinical literature identified through PubMed, Web of Science, CNKI, and Wanfang Data from 1 January 2010 to 30 June 2026. The evidence base comprises 89 intervention entries from 88 reports and 129 distinct study–model combinations, classified as primary-ageing, secondary-context, or acute-atrophy/ in-vitro evidence. Across the specific preparations studied, reported findings mainly concerned protein turnover, inflammatory and fibrotic signaling, mitochondrial quality control, oxidative stress, and satellite-cell regulation. Most findings were treatment–marker associations: only 48/89 entries (53.9%) reported a functional endpoint, while chemical characterization, dose justification, multidose evaluation, causal validation, and safety reporting were limited. Clinical studies remain small and heterogeneous. Overall, the literature supports product-specific biological hypotheses, but clinical efficacy remains unestablished. Priorities for further validation and clinical evaluation are briefly outlined.

Förderung

  • Natural Science Foundation of Inner Mongolia Autonomous Region

Zitieren

APA

Wu, B., Jia, Y., Zhou, M., Hu, Z., Chen, Y., Wei, Y., Liu, Y., & Hou, M. (2026). Selected traditional Chinese medicine preparations for the prevention and treatment of sarcopenia: a critical narrative review. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1975090

Vancouver

Wu B, Jia Y, Zhou M, Hu Z, Chen Y, Wei Y, et al. Selected traditional Chinese medicine preparations for the prevention and treatment of sarcopenia: a critical narrative review. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1975090

BibTeX
@article{Wu2026,
  author = {Wu, Bo and Jia, Yuqi and Zhou, Mingzhang and Hu, Zhongren and Chen, Yanchi and Wei, Ying and Liu, Yan and Hou, Mingxing},
  title = {Selected traditional Chinese medicine preparations for the prevention and treatment of sarcopenia: a critical narrative review},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1975090}
}
Kostenlos starten →